{"rows":[{"id":5765,"title":"Is BOLD Measurement-Invariant Across Pharmacological State? A Pre-Registered Test of Haemodynamic Response Function Drug-Invariance Using Simultaneous EEG-fMRI (PsiConnect)","authors":"Kareem Soliman","journal":"Open MIND","publication_date":"2026-07-28","publication_year":2026,"doi":"10.17605/osf.io/hba3y","pubmed_id":null,"openalex_id":"https://openalex.org/W7171560614","source_url":"https://osf.io/hba3y","substance_tags":"psilocybin","topic_tags":"Chronic Pain,Brain Imaging,Receptor Pharmacology,Toxicity","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-08-01 01:20:23","last_checked":"2026-08-09 08:25:00","bibtex":null,"source_record_id":"DOI:10.17605/osf.io/hba3y","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://osf.io/hba3y","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.17605/osf.io/hba3y","source_url":"https://osf.io/hba3y","doi":"10.17605/osf.io/hba3y","pmid":"","publication_date":"2026-07-28","importer_version":"2.1.3","text_redistributed":false}},{"id":5713,"title":"Psilocybin Therapy for Depression: A Scoping Review Protocol","authors":"Dalton Budhram, Preet Dhaliwal","journal":"Open MIND","publication_date":"2020-01-01","publication_year":2020,"doi":null,"pubmed_id":null,"openalex_id":"https://openalex.org/W7167303937","source_url":"https://osf.io/4syt6","substance_tags":"psilocybin","topic_tags":"Depression,Chronic Pain,Clinical Trial,Review Article,Toxicity","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-11 19:28:11","last_checked":"2026-08-09 08:25:49","bibtex":null,"source_record_id":"https://osf.io/4syt6","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://osf.io/4syt6","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"https://osf.io/4syt6","source_url":"https://osf.io/4syt6","doi":"","pmid":"","publication_date":"2020-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5686,"title":"Therapeutic potential of psilocybin in the pharmacological treatment of obsessive-compulsive disorder: a scoping review protocol.","authors":"Raul Edison Luna Lazo, Nicole Milagritos Cardoso Azorza, Jatziri Yanina Vilca Yanac, Ahmad Kassem El Zein, Omar Abraham Ramírez Paucar, Luana Mota Ferreira, Roberto Pontarolo","journal":"Open MIND","publication_date":"2026-07-09","publication_year":2026,"doi":"10.17605/osf.io/guqxr","pubmed_id":null,"openalex_id":"https://openalex.org/W7167787527","source_url":"https://osf.io/guqxr","substance_tags":"psilocybin,psilocin","topic_tags":"OCD,Chronic Pain,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Review Article,Animal Study,Toxicity","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-11 01:20:14","last_checked":"2026-08-09 08:25:01","bibtex":null,"source_record_id":"DOI:10.17605/osf.io/guqxr","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://osf.io/guqxr","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.17605/osf.io/guqxr","source_url":"https://osf.io/guqxr","doi":"10.17605/osf.io/guqxr","pmid":"","publication_date":"2026-07-09","importer_version":"2.1.3","text_redistributed":false}},{"id":5313,"title":"Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on α Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations","authors":"Michael Kometer, André Schmidt, Lutz Jäncke, Franz X. Vollenweider","journal":"Open MIND","publication_date":"2013-01-01","publication_year":2013,"doi":null,"pubmed_id":null,"openalex_id":"https://openalex.org/W6929930661","source_url":"https://openalex.org/W6929930661","substance_tags":"psilocybin","topic_tags":"Depression,Receptor Pharmacology,Genomics","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:04","last_checked":"2026-08-09 08:25:54","bibtex":null,"source_record_id":"https://openalex.org/W6929930661","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"https://openalex.org/W6929930661","source_url":"https://openalex.org/W6929930661","doi":"","pmid":"","publication_date":"2013-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5223,"title":"Psilocybin and Mescaline - Molecule of the Month October 1999 [Archived version]","authors":"Paul May","journal":"Open MIND","publication_date":"2017-01-01","publication_year":2017,"doi":"10.6084/m9.figshare.5245549.v1","pubmed_id":null,"openalex_id":"https://openalex.org/W3209180968","source_url":"http://www.chm.bris.ac.uk/motm/psilocybin/psilocybinh.htm","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:03","last_checked":"2026-08-09 08:25:52","bibtex":null,"source_record_id":"DOI:10.6084/m9.figshare.5245549.v1","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"http://www.chm.bris.ac.uk/motm/psilocybin/psilocybinh.htm","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.6084/m9.figshare.5245549.v1","source_url":"http://www.chm.bris.ac.uk/motm/psilocybin/psilocybinh.htm","doi":"10.6084/m9.figshare.5245549.v1","pmid":"","publication_date":"2017-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4537,"title":"The therapeutic potential and mechanisms of action of psilocybin-assisted therapy in anorexia nervosa treatment","authors":"Hannah Douglass","journal":"Open MIND","publication_date":"2024-10-10","publication_year":2024,"doi":"10.25560/118978","pubmed_id":null,"openalex_id":"https://openalex.org/W7166080670","source_url":"https://hdl.handle.net/10044/1/118978","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Eating Disorders,Chronic Pain,Neuroplasticity,Brain Imaging,Mechanism of Action,Consciousness,Aging,Resilience,Observational Study,Safety","study_type":"Observational Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:42","last_checked":"2026-08-09 08:25:26","bibtex":null,"source_record_id":"DOI:10.25560/118978","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://hdl.handle.net/10044/1/118978","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.25560/118978","source_url":"https://hdl.handle.net/10044/1/118978","doi":"10.25560/118978","pmid":"","publication_date":"2024-10-10","importer_version":"2.1.3","text_redistributed":false}},{"id":4376,"title":"Psychedelic therapy as relational medicine: psychosocial mechanisms in clinical and naturalistic contexts","authors":"Hannes Kettner","journal":"Open MIND","publication_date":"2025-05-04","publication_year":2025,"doi":"10.25560/125300","pubmed_id":null,"openalex_id":"https://openalex.org/W7124428185","source_url":"https://hdl.handle.net/10044/1/125300","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,End-of-Life Distress,Mechanism of Action,Aging,Wellbeing,Randomized Controlled Trial","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:40","last_checked":"2026-08-09 08:25:20","bibtex":null,"source_record_id":"DOI:10.25560/125300","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://hdl.handle.net/10044/1/125300","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.25560/125300","source_url":"https://hdl.handle.net/10044/1/125300","doi":"10.25560/125300","pmid":"","publication_date":"2025-05-04","importer_version":"2.1.3","text_redistributed":false}},{"id":4175,"title":"Cost-Effectiveness of Psilocybin-Assisted Therapy (PAT) for Patients with Treatment-Resistant Depression","authors":"Yosr Ziadi, Taehwan Park","journal":"Open MIND","publication_date":"2026-01-01","publication_year":2026,"doi":"10.17605/osf.io/nrt59","pubmed_id":null,"openalex_id":"https://openalex.org/W7161800164","source_url":"https://osf.io/nrt59","substance_tags":"psilocybin","topic_tags":"Depression,Chronic Pain,Clinical Trial,Treatment-Resistant Depression","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:37","last_checked":"2026-08-09 08:25:13","bibtex":null,"source_record_id":"DOI:10.17605/osf.io/nrt59","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://osf.io/nrt59","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.17605/osf.io/nrt59","source_url":"https://osf.io/nrt59","doi":"10.17605/osf.io/nrt59","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}}],"total":8,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Open MIND","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}